No excess mortality in contemporary undifferentiated arthritis, in contrast to rheumatoid arthritis: a study with a follow-up of at least 10 years

Ann Rheum Dis. 2022 Aug;81(8):1197-1199. doi: 10.1136/annrheumdis-2022-222145. Epub 2022 Mar 2.
No abstract available

Keywords: anti-citrullinated protein antibodies; antirheumatic agents; arthritis; arthritis, rheumatoid; epidemiology.

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Arthritis, Rheumatoid* / drug therapy
  • Autoantibodies
  • Follow-Up Studies
  • Humans
  • Peptides, Cyclic
  • Rheumatoid Factor

Substances

  • Autoantibodies
  • Peptides, Cyclic
  • Rheumatoid Factor